Interim results of the JULIET trial of CTL019 in R/R DLBCL
Why patients with large B-cell lymphoma fail CAR T-cell therapy & how to manage them
This article explores the potential reasons for relapse following CAR T-cell therapy and the management strategies for this population of large B-cell lymphoma...
Educational theme: Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL
Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month